Your browser doesn't support javascript.
loading
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
Bjelakovic, Goran; Nikolova, Dimitrinka; Gluud, Lise Lotte; Simonetti, Rosa G.; Gluud, Christian.
Afiliación
  • Bjelakovic, Goran; s.af
  • Nikolova, Dimitrinka; s.af
  • Gluud, Lise Lotte; s.af
  • Simonetti, Rosa G.; s.af
  • Gluud, Christian; s.af
São Paulo med. j ; 133(2): 164-165, Mar-Apr/2015.
Artículo en Inglés | LILACS | ID: lil-746640
Biblioteca responsable: BR1.1
ABSTRACT

BACKGROUND:

Our previous systematic review has demonstrated that antioxidant supplements may increase mortality. We have now updated this review.

OBJECTIVES:

To assess the beneficial and harmful effects of antioxidant supplements for prevention of mortality in adults.

METHODS:

Search

methods:

We searched The Cochrane Library, Medline, Embase, Lilacs, the Science Citation Index Expanded, and Conference Proceedings Citation Index-Science to February 2011. We scanned bibliographies of relevant publications and asked pharmaceutical companies for additional trials. Selection criteria We included all primary and secondary prevention randomized clinical trials on antioxidant supplements (beta-carotene, vitamin A, vitamin C, vitamin E, and selenium) versus placebo or no intervention. Data collection and

analysis:

Three authors extracted data. Random-effects and fixed-effect model meta-analyses were conducted. Risk of bias was considered in order to minimize the risk of systematic errors. Trial sequential analyses were conducted to minimize the risk of random errors. Random effects model meta-regression analyses were performed to assess sources of intertrial heterogeneity. MAIN

RESULTS:

Seventy-eight randomized trials with 296,707 participants were included. Fifty-six trials including 244,056 participants had low risk of bias. Twenty-six trials included 215,900 healthy participants. Fifty-two trials included 80,807 participants with various diseases in a stable phase. The mean age was 63 years (range 18 to 103 years). The mean proportion of women was 46%. Of the 78 trials, 46 used the parallel-group design, 30 the factorial design, and 2 the cross-over design. All antioxidants were administered orally, either alone or in combination with vitamins, minerals, or other interventions. The duration of supplementation varied from 28 days to 12 years (mean duration 3 years; median duration 2 years). Overall, the antioxidant supplements had no significant ...
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Bases de datos: LILACS Asunto principal: Prevención Primaria / Mortalidad / Prevención Secundaria / Antioxidantes Tipo de estudio: Ensayo clínico controlado / Estudio pronóstico Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: São Paulo med. j Asunto de la revista: Cirurgia Geral / Ciˆncia / Ginecologia / Medicina / Medicina Interna / Obstetr¡cia / Pediatria / Sa£de Mental / Sa£de P£blica Año: 2015 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Bases de datos: LILACS Asunto principal: Prevención Primaria / Mortalidad / Prevención Secundaria / Antioxidantes Tipo de estudio: Ensayo clínico controlado / Estudio pronóstico Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: São Paulo med. j Asunto de la revista: Cirurgia Geral / Ciˆncia / Ginecologia / Medicina / Medicina Interna / Obstetr¡cia / Pediatria / Sa£de Mental / Sa£de P£blica Año: 2015 Tipo del documento: Artículo